Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 11Neoplasms 5Stomach Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Metastatic Pancreatic Adenocarcinoma 2Head and Neck Neoplasms 2Glioma 2Colorectal Neoplasms 2Biliary Tract Neoplasms 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Pancreatic cancer, adult 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Cystic, Mucinous, and Serous 1Metastatic Adenocarcinoma of the Pancreas 1Mesothelioma 1Malignant Solid Neoplasm 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Endocrine Gland Neoplasms 1Disease 1Digestive System Neoplasms 1

Interventions

veliparib 1irinotecan sucrosofate 1Methods 1Magnetic Resonance Spectroscopy 1Iopamidol 1Ferrosoferric Oxide 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Solid Neoplasm × irinotecan sucrosofate × Clear all
NCT02631733 2025-02-10

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
18 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡